TABLE 1 

Each patient’s gender and age, the presence of anti-GM-CSF autoantibodies in plasma, and species and molecular types of cryptococcal strains isolated from cerebrospinal fluida

PatientRaceGenderAge (yr)AabCryptococcal strain
SpeciesMolecular type
C1ChineseFemale37C. neoformansNA
C2ChineseMale55C. neoformansNA
C3ChineseFemale46C. neoformansVNI
C4ChineseMale28C. neoformansNA
C5ChineseFemale37C. neoformansNA
C6ChineseFemale32C. neoformansNA
C7ChineseMale22C. neoformansVNI
C8ChineseMale10C. neoformansNA
C9ChineseMale45C. neoformansVNI
C10ChineseMale57C. neoformansVNI
C11ChineseFemale40C. neoformansNA
C12ChineseMale4C. neoformansNA
C13ChineseMale61C. neoformansNA
C14ChineseMale42C. neoformansVNIII
C15ChineseMale55C. neoformansVNI
C16ChineseMale32C. neoformansNA
C17ChineseFemale49+C. gattiiVGI
C18ChineseMale40C. neoformansNA
C19ChineseMale56C. neoformansNA
C20ChineseFemale40C. neoformansNA
C21ChineseMale43C. neoformansNA
A1CaucasianFemaleNA+C. gattiiVGI
A2CaucasianFemaleNA+C. gattiiVGI
A3CaucasianMaleNA+C. gattiiVGI
A4AborigineFemaleNA+C. gattiiVGI
A5CaucasianFemaleNAC. gattiiVGI
A6Asian (Indian)FemaleNAC. neoformansNA
A7AsianFemaleNA+C. gattiiVGI
A8CaucasianMaleNA+C. gattiiVGII
A9Asian (Filipino)MaleNAC. gattiiVGI
  • a Aab, anti-GM-CSF autoantibody; C, patients in China; A, patients in Australia; NA, not available for this study.